NCT05910294
A Study to Prevent and Improve Sexual Health Concerns for People With Breast Cancer
Recruiting
NAAges 18+InterventionalPreventionMemorial Sloan Kettering Cancer CenterInvestigator-initiated
~50 participants
Updated 2026-04-01 on ClinicalTrials.gov
What's tested:questionnairesmoisturizers
At a glance
Recruiting sites
7 of 7 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of participants with a score of 4 or greater in VAS
Measured over 1 year
Conditions
Where it's being run
7 sites across 2 statesNew York4
New Jersey3
Study leadership
- Shari Goldfarb, MD · PRINCIPAL_INVESTIGATOR · Memorial Sloan Kettering Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Women, 18 years of age or older
Breast cancer patients with hormone receptor positive breast cancer , stage 0-III
Premenopausal or perimenopausal women who have either been pregnant or had at least one menstrual period in the last 24 months or have/had an IUD in place
Patients currently on or are being initiated on ovarian suppression
Patients are asymptomatic for vaginal symptoms of estrogen deprivation (i.e. vaginal dryness, dyspareunia, or discomfort \[pain with intercourse or examination\]) and score a 3 or less on the VAS and VuAS
Exclusion
Postmenopausal women who have been without a period for ≥ 2 years
Patients who score a 4 or above on the VAS and VuAS
Patients already using VVA treatment (e.g. intravaginal estrogen, other non-hormonal moisturizer or suppository), unless discontinued with washout of 4 weeks
What this trial measures
- Number of participants with a score of 4 or greater in VAS1 year
measured by the Vaginal Assessment Scale (VAS)